Skip to content

Drug interactions

Givosiran + Sofosbuvir-velpatasvir-voxilaprevir

Severity: Minor

Givosiran and Sofosbuvir-velpatasvir-voxilaprevir: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Givosiran may reduce CYP1A2 activity and increase exposure to CYP1A2 substrates. Voxilaprevir is mostly cleared via other pathways, so a meaningful effect is unlikely.

What this interaction means in plain words

Givosiran and Sofosbuvir-velpatasvir-voxilaprevir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Givosiran belongs to Miscellaneous; Sofosbuvir-velpatasvir-voxilaprevir belongs to Anti Virals.

Evidence level: Low

Why it happens

Givosiran may inhibit CYP1A2, which is a minor route of voxilaprevir metabolism.

What to do

No routine action needed; monitor for adverse effects of the HCV regimen.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Givosiran and Sofosbuvir-velpatasvir-voxilaprevir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Givosiran with Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp rates the interaction as minor. Givosiran and Sofosbuvir-velpatasvir-voxilaprevir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Givosiran may reduce CYP1A2 activity and increase exposure to CYP1A2 substrates. Voxilaprevir is mostly cleared via other pathways, so a meaningful effect is unlikely.

How serious is the interaction between Givosiran and Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine action needed; monitor for adverse effects of the HCV regimen.

What other medicines interact with Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp also lists interactions of Sofosbuvir-velpatasvir-voxilaprevir with, for example, Fosphenytoin, Phenobarbital, Phenytoin. The full list is on the Sofosbuvir-velpatasvir-voxilaprevir page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in